A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among
(2010) In Human Molecular Genetics 19(15). p.3089-3101- Abstract
- The insulin-like growth factor (IGF) pathway has been implicated in prostate development and carcinogenesis. We conducted a comprehensive analysis, utilizing a resequencing and tagging single-nucleotide polymorphism (SNP) approach, between common genetic variation in the IGF1, IGF binding protein (BP) 1, and IGFBP3 genes with IGF-I and IGFBP-3 blood levels, and prostate cancer (PCa) risk, among Caucasians in the NCI Breast and Prostate Cancer Cohort Consortium. We genotyped 14 IGF1 SNPs and 16 IGFBP1/IGFBP3 SNPs to capture common [minor allele frequency (MAF) >= 5%] variation among Caucasians. For each SNP, we assessed the geometric mean difference in IGF blood levels (N = 5684) across genotypes and the association with PCa risk (6012... (More)
- The insulin-like growth factor (IGF) pathway has been implicated in prostate development and carcinogenesis. We conducted a comprehensive analysis, utilizing a resequencing and tagging single-nucleotide polymorphism (SNP) approach, between common genetic variation in the IGF1, IGF binding protein (BP) 1, and IGFBP3 genes with IGF-I and IGFBP-3 blood levels, and prostate cancer (PCa) risk, among Caucasians in the NCI Breast and Prostate Cancer Cohort Consortium. We genotyped 14 IGF1 SNPs and 16 IGFBP1/IGFBP3 SNPs to capture common [minor allele frequency (MAF) >= 5%] variation among Caucasians. For each SNP, we assessed the geometric mean difference in IGF blood levels (N = 5684) across genotypes and the association with PCa risk (6012 PCa cases/6641 controls). We present two-sided statistical tests and correct for multiple comparisons. A non-synonymous IGFBP3 SNP in exon 1, rs2854746 (Gly32Ala), was associated with IGFBP-3 blood levels (P-adj = 8.8 x 10(-43)) after adjusting for the previously established IGFBP3 promoter polymorphism A-202C (rs2854744); IGFBP-3 blood levels were 6.3% higher for each minor allele. For IGF1 SNP rs4764695, the risk estimates among heterozygotes was 1.01 (99% CI: 0.90-1.14) and 1.20 (99% CI: 1.06-1.37) for variant homozygotes with overall PCa risk. The corrected allelic P-value was 8.7 x 10(-3). IGF-I levels were significantly associated with PCa risk (P-trend = 0.02) with a 21% increase of PCa risk when compared with the highest quartile to the lowest quartile. We have identified SNPs significantly associated with IGFBP-3 blood levels, but none of these alter PCa risk; however, a novel IGF1 SNP, not associated with IGF-I blood levels, shows preliminary evidence for association with PCa risk among Caucasians. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1654435
- author
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Human Molecular Genetics
- volume
- 19
- issue
- 15
- pages
- 3089 - 3101
- publisher
- Oxford University Press
- external identifiers
-
- wos:000280491200015
- scopus:77958190951
- pmid:20484221
- ISSN
- 0964-6906
- DOI
- 10.1093/hmg/ddq210
- language
- English
- LU publication?
- yes
- id
- 80394e52-3c90-477e-b033-48a771acc27c (old id 1654435)
- date added to LUP
- 2016-04-01 09:53:44
- date last changed
- 2022-02-17 04:38:00
@article{80394e52-3c90-477e-b033-48a771acc27c,
abstract = {{The insulin-like growth factor (IGF) pathway has been implicated in prostate development and carcinogenesis. We conducted a comprehensive analysis, utilizing a resequencing and tagging single-nucleotide polymorphism (SNP) approach, between common genetic variation in the IGF1, IGF binding protein (BP) 1, and IGFBP3 genes with IGF-I and IGFBP-3 blood levels, and prostate cancer (PCa) risk, among Caucasians in the NCI Breast and Prostate Cancer Cohort Consortium. We genotyped 14 IGF1 SNPs and 16 IGFBP1/IGFBP3 SNPs to capture common [minor allele frequency (MAF) >= 5%] variation among Caucasians. For each SNP, we assessed the geometric mean difference in IGF blood levels (N = 5684) across genotypes and the association with PCa risk (6012 PCa cases/6641 controls). We present two-sided statistical tests and correct for multiple comparisons. A non-synonymous IGFBP3 SNP in exon 1, rs2854746 (Gly32Ala), was associated with IGFBP-3 blood levels (P-adj = 8.8 x 10(-43)) after adjusting for the previously established IGFBP3 promoter polymorphism A-202C (rs2854744); IGFBP-3 blood levels were 6.3% higher for each minor allele. For IGF1 SNP rs4764695, the risk estimates among heterozygotes was 1.01 (99% CI: 0.90-1.14) and 1.20 (99% CI: 1.06-1.37) for variant homozygotes with overall PCa risk. The corrected allelic P-value was 8.7 x 10(-3). IGF-I levels were significantly associated with PCa risk (P-trend = 0.02) with a 21% increase of PCa risk when compared with the highest quartile to the lowest quartile. We have identified SNPs significantly associated with IGFBP-3 blood levels, but none of these alter PCa risk; however, a novel IGF1 SNP, not associated with IGF-I blood levels, shows preliminary evidence for association with PCa risk among Caucasians.}},
author = {{Schumacher, Fredrick R. and Cheng, Iona and Freedman, Matthew L. and Mucci, Lorelei and Allen, Naomi E. and Pollak, Michael N. and Hayes, Richard B. and Stram, Daniel O. and Canzian, Frederico and Henderson, Brian E. and Hunter, David J. and Virtamo, Jarmo and Manjer, Jonas and Gaziano, J. Michael and Kolonel, Laurence N. and Tjonneland, Anne and Albanes, Demetrius and Calle, Eugenia E. and Giovannucci, Edward and Crawford, E. David and Haiman, Christopher A. and Kraft, Peter and Willett, Walter C. and Thun, Michael J. and Marchand, Loic Le and Kaaks, Rudolf and Feigelson, Heather Spencer and Bueno-de-Mesquita, H. Bas and Palli, Domenico and Riboli, Elio and Lund, Eliv and Amiano, Pilar and Andriole, Gerald and Dunning, Alison M. and Trichopoulos, Dimitrios and Stampfer, Meir J. and Key, Timothy J. and Ma, Jing}},
issn = {{0964-6906}},
language = {{eng}},
number = {{15}},
pages = {{3089--3101}},
publisher = {{Oxford University Press}},
series = {{Human Molecular Genetics}},
title = {{A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among}},
url = {{http://dx.doi.org/10.1093/hmg/ddq210}},
doi = {{10.1093/hmg/ddq210}},
volume = {{19}},
year = {{2010}},
}